Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with ΔE1, ΔE3 recombinant adenovirus vectors

被引:24
|
作者
Hirschowitz, E [1 ]
Hidalgo, G [1 ]
Doherty, D [1 ]
机构
[1] Univ Kentucky, Albert B Chandler Med Ctr, Div Pulm & Crit Care Med, Lexington Vet Adm Med Ctr, Lexington, KY 40536 USA
关键词
adenovirus; ERK; COX-2; PGE-2; non-small cell lung cancer (NSCLC);
D O I
10.1038/sj.gt.3301621
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infection of epithelial-derived cells by adenovirus vectors has myriad effects on cellular behavior and function. Some are relevant to the desired effect of the encoded transgene and therapeutic goals of gene therapy approach. The current experiments describe the induction of COX-2 protein and PGE-2 production by non-small cell lung cancer (NSCLC) cells following infection with a first generation (DeltaE1, DeltaE3) Ad vector. COX-2 overexpression by malignant cells has been shown to enhance cellular invasion, induce anglogenesis, regulate anti-apoptotic cellular defenses and augment immunologic resistance through production of PGE-2. Data show DeltaE1, DeltaE3, Ad5 vector infection induces dose-dependent increases in PGE-2 production by NSCLC cell lines. Data with UV/psoralen inactivated vectors and control vectors show this effect is dependent on Ad vector gene expression, but independent of the transgene expressed. Selective blockade of ERK with PD98029 abrogated induction of PGE-2 by Ad vectors. Consistent with these data, detectable increases in COX-2 protein were seen at 48 h after infection by Western blot that were paralleled by increases in the phosphorylation of ERK-1/2. UV/psoralen-inactivated vector did not induce COX-2 protein or ERK phosphorylation at 48 h. Further, an inhibitor of NF-kappa B (NFkappaB) translocation to the nucleus, SN50, had no effect on PGE-2 levels. In contrast, Ad vector infection did induce NFkappaB activity measured by NFkappaB-luciferase reporter plasmid, transfected into a NSCLC cell line. Collectively the data indicate DeltaE1, DeltaE3, Ad5 vector infection leads to ERK phosphorylation with parallel increases in COX-2 protein and PGE-2 production. These effects appear unrelated to NFkappaB and are dependent on gene expression by the vector. This information may need to be considered when defining targets for cancer gene therapy and/or the choice of viral vector.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 50 条
  • [21] LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer
    Liu, Meiyuan
    Cai, Rui
    Wang, Tian
    Yang, Xia
    Wang, Meng
    Kuang, Zhongsheng
    Xie, Yuhui
    Zhang, Jiren
    Zheng, Yanfang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (17)
  • [22] FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
    Hong Yuan
    Zi-Ming Li
    Jiaxiang Shao
    Wen-Xiang Ji
    Weiliang Xia
    Shun Lu
    Journal of Experimental & Clinical Cancer Research, 36
  • [23] FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
    Yuan, Hong
    Li, Zi-Ming
    Shao, Jiaxiang
    Ji, Wen-Xiang
    Xia, Weiliang
    Lu, Shun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [24] Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines
    Duarte, Mariana Lemos
    de Moraes, Emanuela
    Pontes, Elizangela
    Schluckebier, Luciene
    de Moraes, Joyce Luana
    Hainaut, Pierre
    Ferreira, Carlos Gil
    CANCER LETTERS, 2009, 279 (01) : 57 - 64
  • [25] Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
    Shimizu, Katsuhiko
    Okita, Riki
    Saisho, Shinsuke
    Maeda, Ai
    Nojima, Yuji
    Nakata, Masao
    ANTICANCER RESEARCH, 2018, 38 (08) : 4637 - 4644
  • [27] Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors
    Imler, JL
    Chartier, C
    Dreyer, D
    Dieterle, A
    SainteMarie, M
    Faure, T
    Pavirani, A
    Mehtali, M
    GENE THERAPY, 1996, 3 (01) : 75 - 84
  • [28] A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer
    Migliorino, MR
    De Marinis, F
    Nelli, F
    Facciolo, F
    Ammaturo, MV
    Cipri, A
    Belli, R
    Ariganello, O
    Diana, F
    Di Molfetta, M
    Martelli, O
    LUNG CANCER, 2002, 35 (03) : 319 - 327
  • [29] Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance
    Manhua Ding
    Liang Liu
    Chengxi Hu
    Yi Liu
    Yun Qiao
    Xiaodong Jiang
    ChineseJournalofCancerResearch, 2014, 26 (06) : 669 - 677
  • [30] Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance
    Ding, Manhua
    Liu, Liang
    Hu, Chengxi
    Liu, Yi
    Qiao, Yun
    Jiang, Xiaodong
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (06) : 669 - 677